Publications by authors named "Vanessa Di Cataldo"

Claim this Profile
I
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo, Pietro Garlatti, Michele Aquilano

Prostate Cancer Prostatic Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.
Giulio Francolini, Vanessa Di Cataldo, Pietro Garlatti, Niccolò Bertini, Michele Aquilano

BJU Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START).
Giulio Francolini, Vanessa Di Cataldo, Saverio Caini, Barbara A Jereczek-Fossa, Giulia Marvaso

Radiother Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914).
Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, Saverio Caini, Mauro Loi

Radiol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736): An Early Analysis from the STARR Trial.
Niccolo' Bertini, Giulio Francolini, Vanessa Di Cataldo, Pietro Garlatti, Michele Aquilano

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes.
Miriam Tomaciello, Antonio Sciurti, Luisa Caprara, Miriam Conte, Viviana Frantellizzi, Vanessa Di Cataldo

Int J Radiat Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Long-term clinical outcome and favorable predictive factors.
Viola Salvestrini, Ilaria Bonaparte, Carlotta Becherini, Isacco Desideri, Saverio Caini, Vanessa Di Cataldo

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.
Jianzhou Chen, Antonin Levy, Ai-Ling Tian, Xuehan Huang, Guoxin Cai, Vanessa Di Cataldo

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation.
Livia Marrazzo, Deborah Chilà, Immacolata Vanore, Roberto Pellegrini, Peter Voet, Vanessa Di Cataldo

Adv Radiat Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Deprivation Therapy in Intermediate Prostate Cancer Treated With Radiation Therapy: The Wide Heterogeneity and Complexity of an Apparently Simple Situation.
Giulio Francolini, Vanessa Di Cataldo, Pietro Garlatti, Gabriele Simontacchi, Lorenzo Livi

Int J Radiat Oncol Biol Phys· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.
Gabriella Macchia, Savino Cilla, Donato Pezzulla, Maura Campitelli, Concetta Laliscia, Vanessa Di Cataldo

Gynecol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study.
Savino Cilla, Maura Campitelli, Maria Antonietta Gambacorta, Raffaella Michela Rinaldi, Francesco Deodato, Vanessa Di Cataldo

Radiother Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis.
Giulio Francolini, Arunangshu Ghoshal, Saverio Caini, Tessa Piazzini, Carlotta Becherini, Vanessa Di Cataldo

Radiother Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic reirradiation with Cyberknife for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort.
Giulio Francolini, Maria Grazia Carnevale, Vanessa Di Cataldo, Mauro Loi, Beatrice Detti

Radiol Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Giulio Francolini, Andrea Gaetano Allegra, Beatrice Detti, Vanessa Di Cataldo, Saverio Caini

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Giulio Francolini, Angelo Porreca, Gaetano Facchini, Daniele Santini, Alessio Bruni, Vanessa Di Cataldo

Med Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, Luca Triggiani, Nicola Simoni

Radiol Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups.
Gabriella Macchia, Donato Pezzulla, Maura Campitelli, Concetta Laliscia, Andrei Fodor, Vanessa Di Cataldo

Int J Radiat Oncol Biol Phys· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study.
Giulio Francolini, Marco Banini, Vanessa Di Cataldo, Beatrice Detti, Saverio Caini

Prostate· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative single fraction breast radiotherapy: Intra-fraction geometric uncertainties and dosimetric implications.
Laura Masi, Raffaela Doro, Vanessa Di Cataldo, Giulio Francolini, Margherita Zani

Phys Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results.
Giulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, Beatrice Detti, Saverio Caini

Clin Exp Metastasis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choline PET/CT in recurrent prostate cancer.
Beatrice Detti, Maria Grazia Carnevale, Sara Lucidi, Luca Burchini, Saverio Caini, Vanessa di Cataldo

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736).
Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy.
Giulio Francolini, Giulio Frosini, Vanessa Di Cataldo, Beatrice Detti, Maria Grazia Carnevale

J Geriatr Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer.
Giulio Francolini, Vanessa Di Cataldo, Beatrice Detti, Gabriele Simontacchi, Mauro Loi

Clin Exp Metastasis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis